Anna Ferrer
Impact in
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Lymphoma Diagnosis and Treatment 3
- Co-authors
- Eugeni Saigí (1 shared paper)Álex Casalots (1 shared paper)Carles Pericay (1 shared paper)Xavier Serra‐Aracil (1 shared paper)E. Dotor (1 shared paper)Anna Ruiz (1 shared paper)Juhani Vilpo (3 shared papers)Yan Aalto (3 shared papers)
- Journals
- BMC Genomics (2 papers)British Journal of Haematology (2 papers)PLoS ONE (1 paper)Journal of Environmental Sciences (1 paper)Oncology Reports (1 paper)
- Partner nations
- SpainUnited StatesFinland
In The Last Decade
Anna Ferrer
10 papers receiving 491 citations
Peers
Comparison fields: 5 of 53
- Genetics 180
- Cancer Research 162
- Pathology and Forensic Medicine 158
- Immunology 87
- Hematology 39
Countries citing papers authored by Anna Ferrer
This map shows the geographic impact of Anna Ferrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Ferrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Ferrer more than expected).
Fields of papers citing papers by Anna Ferrer
This network shows the impact of papers produced by Anna Ferrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Ferrer. The network helps show where Anna Ferrer may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Ferrer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 143 | |
| 2 | 2002 | 142 | |
| 3 | 2003 | 89 | |
| 4 | 2004 | 30 | |
| 5 | 2013 | 26 | |
| 6 | 2009 | 23 | |
| 7 | 2011 | 19 | |
| 8 | 2013 | 13 | |
| 9 | Lymphotoxin beta expression is high in chronic lymphocytic leukemia but low in small lymphocytic lymphoma: a quantitative real-time reverse transcriptase polymerase chain reaction analysis. | 2003 | 12 |
| 10 | 2017 | 5 | |
| 11 | 2024 | 0 |
About Anna Ferrer
Anna Ferrer is a scholar working on Pathology and Forensic Medicine, Molecular Biology, Genetics, Immunology and Cancer Research, having authored 11 papers that have together received 502 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (3 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), MicroRNA in disease regulation (2 papers), Chronic Myeloid Leukemia Treatments (1 paper), Water-Energy-Food Nexus Studies (1 paper), Acute Lymphoblastic Leukemia research (1 paper) and Microplastics and Plastic Pollution (1 paper). The work is most often cited by research in Genetics (180 citations), Cancer Research (162 citations), Pathology and Forensic Medicine (158 citations), Immunology (87 citations) and Hematology (39 citations). Anna Ferrer has collaborated with scholars based in Spain, United States and Finland. Frequent co-authors include Eugeni Saigí, Álex Casalots, Carles Pericay, Xavier Serra‐Aracil, E. Dotor, Anna Ruiz, Juhani Vilpo, Yan Aalto, Sakari Knuutila and Bálint Nagy. Their work appears in journals such as BMC Genomics, British Journal of Haematology, PLoS ONE, Journal of Environmental Sciences and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.